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Novel strategies for the synthesis of unsymmetrical glycosyl disulfides 
Goreti Ribeiro Morais,* Bradley R Springett, Martin Pauze, Lisa Schröder, Matthew Northrop and Robert A 
Falconer*
Novel strategies for the efficient synthesis of unsymmetrical glycosyl disulfides are reported. Glycosyl disulfides are increasingly important as 
glycomimetics and molecular probes in glycobiology. Sialosyl disulfides are synthesised directly from the chlorosialoside Neu5Ac2Cl, proceeding 
via a thiol-disulfide exchange reaction between the sialosyl thiolate and symmetrical disulfides. This methodology was adapted and found to be 
successfully applicable to the synthesis of unsymmetrical glucosyl disulfides under mild conditions. 
Introduction 
Although less studied than thioglycosides, interest in glycosyl 
disulfides has increased significantly over recent years, particularly 
with their key potential as glycomimetics.
1-3
 For instance, glycosyl
disulfides have shown affinity to lectin Concanavalin A,
3-6
 while 
other disulfides have been successfully employed as tools to aid 
understanding of carbohydrate structures.
7, 8
Moreover, the 
significant utility and advantages of glycosyl disulfides as glycosyl 
donors in the synthesis of a variety of glycosides
9-13
 and
oligosaccharides
2, 14, 15
has been demonstrated following the 
seminal work of the Davis group, with wide applications to the 
synthesis of glycopeptides
13, 16
 and vaccines.
17
 Whilst not widely
employed to-date, sialosyl disulfides possess equal potential for 
application to the synthesis of O-, S- and oligosialosides.  
To the best of our knowledge, and contrarily to glycosyl disulfides, 
there is only one report describing the preparation of sialosyl 
disulfides (by Hummel). This is achieved by means of a diethyl S-
azodicarboxylate as a sulfenyl transfer reagent to the S-sialosyl 
moiety.
18
 On the other hand, several synthetic methodologies have 
been developed for the synthesis of glycosyl disulfides. Briefly, 
symmetrical glycosyl disulfides can be rapidly prepared by the 
oxidation of the corresponding glycosyl thiols,
4, 19-21
 while
unsymmetrical glycosyl disulfides can be prepared by reaction of a 
suitable electrophilic sulfur-based glycosylsulfenyl-transfer reagent, 
such as nitropyridine sulfides,
22
 alkylthiosulfonates esters,
7-10
 
selenylsulfides,
2
 sulfenamides,
23
 and sulfenic acids
24
 with thiols.
Additionally, the Ramström group successfully extended their 
phosphine-catalysed disulfide methathesis conditions
25
 to the 
synthesis of unsymmetrical glycosyl disulfides.
26
These strategies generally require laborious synthesis and 
purification of the glycosylsulfenylating agents, which are 
occasionally unstable and often obtained only in moderate yields. 
We ourselves developed a one-pot synthesis of glycosyl disulfides in 
good to excellent yields via the use of an in situ 
glycosylsulfenylhydrazine derivative from 1-thiogycosides.
27
 Szilágyi
et al. reported preparation of unsymmetrical glycosyl disulfides 
using 1-chlorobenzotriazole as oxidising agent, trapping the sulfenyl 
radicals in an one-pot fashion, albeit under strict temperature 
control (-78 °C).
28
 
Having previously identified the acetyl disulfide sialoside 
(Neu5Ac2SSAc) 1 as a by-product during the routine synthesis of 2-
thioacetyl sialoside (Neu5Ac2SAc) 2 (Figure 1) when 2-
chlorosialoside 3 is reacted with KSAc,
29
 we were motivated to 
explore its utility in the preparation of sialosyl disulfides, and to 
explore whether there were wider applications for glycosyl 
disulfides. 
Results and Discussion 
Given that formation of by-product 1 was markedly dependent on 
the batch of commercial KSAc, with varied levels of oxidation,
29
 our
initial efforts were focused on the synthesis of this compound. We 
initially reacted 2-chlorosialoside 3 with KSAc in the presence of an 
oxidising agent (I2, Scheme 1). Under these conditions, the partial in 
situ oxidation of KSAc to AcSSAc successfully promoted the 
formation of 1 from 3 as major product in 80 % yield. An excess of 
KSAc and longer reaction times (48 h at room temperature) were 
required to effect complete conversion to 1. Shortening of reaction 
times and heating led to several undesirable and unidentified sialic 
acid-related species and a higher percentage of the 2,3-elimination 
by-product Neu5Ac2en, which often plagues reactions of this 
type.
30
 
Figure 1 
Scheme 1 
Furthermore, we have investigated the optimal experimental 
conditions for the preparation of sialosyl disulfides through the 
alkylation of 1 with ethyl iodide (Scheme 2). The reactions were 
monitored by 
1
H NMR spectroscopy. Despite its instability to 
diethylamine treatment, Neu5Ac2SSAc 1 was partially alkylated to 
form the corresponding ethyl disulfide sialoside 4a (50 %) together 
with the corresponding thiosialoside 4b (50 %). Other bases were 
thus investigated. Triethylamine, diisopropylamine, 
diisopropylethylamine proved insufficient to promote S-
deacetylation of the SSAc group, even after 2 h at RT, with 1 being 
fully recovered from the reaction. Morpholine and hydrazine 
hydrate successfully promoted S-deacetylation of sialoside 1, but 
with side reactions, i.e. formation of 5a and 5b, and no alkylated 
products. The use of hydrazine acetate, however, led to the desired 
SS-alkylated product 4a, together with non-alkylated disulfide 
sialoside 5a. Reaction times longer than 15 minutes also led to the 
formation of the undesired 4b. Given these findings, we reasoned 
that performing the same reaction with both hydrazine acetate and 
triethylamine simultaneously should yield the desired product, with 
an absence of break-down products. This proved to be the case: 
sialoside 1 was fully and efficiently converted into sialosyl disulfide 
4a in only 10 min at 50 ˚C.  Acetyl disulfide 1 is thus a convenient 
and efficient route to sialosyl disulfides under these conditions. 
 
To begin to evaluate the wider applicability of these findings, we 
explored the scope of this reaction by employing different aryl and 
alkyl bromides (Table 1). Under these optimised conditions, 
sialoside 1 proved to be highly reactive to both benzyl- (Entry 2, 
Table 1) and 4-fluorobenzyl bromide (Entry 5, Table 1) with 
formation of only the desired product, the respective sialosyl 
disulfides 6a and 6b, obtained in fair to good yields. In addition to 
DMF, this SS-alkylation reaction was also performed in other 
solvents such as dichloroethane (Entry 3, Table 1) and acetonitrile 
(Entry 4, Table 1) at 50 ˚C for 10 min. In these cases conversion of 1 
into 6a was inefficient, with an additional sialic acid-related by-
product detected by 
1
H NMR. DMF was confirmed as the preferred 
solvent for these reactions. We also confirmed that when either 
hydrazine acetate or triethylamine were utilised alone with benzyl 
bromide in dichloroethane, no product was observed, with 1 being 
fully recovered. When reacting with the less electrophilic cinnamyl 
bromide (Entry 6, Table 1), however, two products were detected 
by TLC (we were unable to isolate these products for further 
investigation). After purification (flash column chromatography), 
sialosyl disulfide 6c was obtained in low yield (22 %).  
 
In summary, acetyl disulfide sialoside 1 was demonstrated to be an 
easily synthesised and useful intermediate for the preparation of 
some sialosyl disulfides. However, with respect to its limited 
reactivity to weak electrophiles, associated with side reactions and 
poor yields, this strategy was deemed sub-optimal as a general 
method for the synthesis of unsymmetrical sialosyl disulfides. With 
a view to arriving at a more widely applicable methodology, we 
thus re-designed our synthetic strategy. 
 
 
Scheme 2 
 
Table 1 
 
 
Entry RX Solvent Product 
Yield 
(%) 
1 ethyl iodide DMF 4a -a 
2 benzyl bromide DMF 6a 54b 
3 benzyl bromide DCE 6a -c 
4 benzyl bromide MeCN 6a -d 
5 4-fluorobenzyl bromide DMF 6b 79b 
6 cinnamyl bromide DMF 6c 22b 
  
a.1
H NMR analysis indicated complete conversion of 1 into 4a; 
b.
Isolated yields; 
c..1
H 
NMR analysis indicated 74 % of 6a; d..1H NMR analysis indicated 65% of 6a. 
 
 
Whilst previously investigating the mechanism by which acetyl 
disulfide sialoside 1 is formed, we established that 2-chlorosialoside 
3 was unreactive towards AcSSAc. This observation ruled out direct 
nucleophilic attack of a putative acetyl disulfide anion (AcSS
-
) on the 
electrophilic anomeric carbon. Repetition of this reaction in the 
presence of KSAc, however, promoted the formation of 
Neu5Ac2SSAc 1, which suggested that the source of 1 is in fact the 
sialosyl thioacetate, Neu5Ac2SAc 2.
29
 Moreover, we also found that 
formation of Neu5AcSSAc 1 from pure Neu5Ac2SAc 2 and AcSSAc 
was only achieved when KSAc was present. This finding suggests 
that KSAc promotes the selective S-deacetylation of the thioacetate 
group of 2 and that the thiolate anion generated reacts with the 
electrophilic sulfur of the symmetrical acetyl disulfide to produce 
the Neu5Ac2SSAc 1 through a thio-disulfide exchange mechanism. 
Reactions between thiols and symmetrical disulfides, similar to that 
observed in vivo between thiols and glutathione, have been well 
explored albeit with limited success in organic chemistry for the 
synthesis of non-glycosidic unsymmetrical disulfides.
31, 32
 In the 
same way, we demonstrated that when 2 is reacted with 
symmetrical benzyl disulfide BnSSBn in the presence of KSAc, 
Neu5Ac2SSBn 6a is formed (Scheme 3). 
1
H NMR analysis of this 
reaction showed that after 1 h sialoside 2 had been converted into 
6a in very good yield (75 %).  
 
Based on the finding that KSAc, which is crucial for the preparation 
of Neu5Ac2SAc 2, also efficiently promotes the reaction of 2 with 
symmetrical disulfide BnSSBn, we thought it interesting to attempt 
formation of Neu5Ac2SSBn 6a directly from chlorosugar Neu5Ac2Cl 
3. This would remove the need for separate thiosialoside synthesis. 
1
H NMR experiments indicated that when 3 and BnSSBn were 
reacted in the presence of KSAc, no Neu5Ac2SSBn 6a was observed 
after a 3 h reaction, and that 3 had not been completely converted 
into 2. When 3 and KSAc were reacted for several hours prior to 
addition of BnSSBn, however, Neu5Ac2SSBn 6a was formed in 33 % 
after 9 h. This two-step one-pot reaction was drastically improved 
when a base (diethylamine) was added with the BnSSBn. Neu5Ac2Cl 
3 was completely converted into Neu5Ac2SSBn 6a in 1 h. These 
conditions could also be applied to the synthesis of other benzyl 
and phenyl sialosyl disulfides (entries 2 and 4, Table 2).  
 
This methodology could be utilised to successfully prepare the 
forementioned cinnamyl sialosyl disulfide 6c (entry 3, Table 2). 
As expected, aliphatic symmetrical disulfides were found to be 
less reactive towards chlorosugar 3, with longer reaction times 
(2 h to overnight) required (entries 6, 7, and 9, Table 2). 
Hydroxyl-functionalised disulfides were also amenable in these 
conditions, with 7d being obtained in good yield after a 2 hr 
reaction (entry 7, Table 2). When a heteroaromatic disulphide 
(entry 8) was reacted under these conditions, the respective 
thiosialoside was also observed in equal amounts to the 
disulphide 7e. This presumably results from the competitive 
nucleophilic attack of the in situ formed (and relatively more 
reactive) 5-chloropyridin-2-mercaptan to the unreacted 
chlorosialosyl 3. Formation of this thiosialoside was minimised 
by first reacting chlorosialoside 3 with KSAc followed by the 
addition of 5-chloropyridin-2-disulfide and base after 6 h.  
We have thus identified convenient conditions for the 
synthesis of sialosyl disulfides, starting from either the 2-
chlorosialoside 3 or 2-thioacetate 2. 
 
We subsequently sought to establish wider applicability to the 
broader glycoside field. D-glucose was selected as being generally 
representative. In this case, diethylamine was found to be 
insufficient to promote the synthesis of glucosyl disulfides. Other 
organic bases such as diisopropylethylamine and morpholine 
proved to be equally insufficient. Hydrazine hydrate efficiently 
promoted the thiol-disulfide exchange reaction between glucosyl 
thioacetate 8 and the symmetrical disulfide of interest, however. 
The method proved successful for a similar range of alkyl and aryl 
disulfides, resulting in glucosyl disulfides being successfully 
synthesised from 1-thioacetate derivative 8 in good yields (Table 3). 
Previous reports describing the synthesis of glucosyl disulfides from 
glucosyl thioacetate 8 employed sodium hydroxide, which leads 
also to complete hydrolysis of O-acetate protecting groups.
33
 
Hydrazine hydrate is more suitable in this regard.  
 
 
 
Scheme 3 
 
 
Table 2 
 
Entry R Product Yield (%) 
1 benzyl  6a 65 
2 4-fluorobenyl 6b 62 
3 cinnamyl 6c 56 
4 phenyl 7a 75 
5 per-O-acetyl-glucose 7b 61 
6 methyl 7c 71 
7 2-hydroxyethyl 7d 64 
8 5-chloropyridin-2-yl 7e 69a 
9 cyclohexyl 7f 60 
a.Corrected yield by 1H NMR 
   
 
Table 3 
  
Entry R Product Yield (%) 
1 2-hydroxyl ethyl 9a 49 
2 cyclohexyl 9b 58 
3 phenyl 9c 65 
4 benzyl 9d 60a 
5 4-fluorobenzyl 9e 52b 
6 methyl 9f 65 
7 5-chloropyridin-2-yl 9g 66 
a.Yield calculated by 1H NMR; b.1H NMR of the crude indicated full conversion of 
8 into 9e
Conclusions 
In summary, we report novel strategies for the synthesis of 
unsymmetrical sialosyl and glycosyl disulfides, offering 
significant advantages over existing methodologies, employing 
readily utilised intermediates. This methodology offers a 
convenient route to compounds of biological interest, with 
potential as carbohydrate probes or enzyme inhibitors. Given 
the increasing awareness of the importance of carbohydrates 
in biological processes, e.g. cancer progression and 
metastasis,
34, 35
 the field of synthesis of carbohydrate mimetics 
and probes such as glycosyl disulfides will continue to gain 
pace.  
 
Experimental 
General information 
NMR spectra were generated on a JEOL ECA-600 and Bruker AMX 
400 operating at 600 MHz and 400 MHz respectively. Chemical 
shifts are reported in ppm downfield relative to tetramethylsilane 
(solvent CDCl3). Low resolution mass spectra (LRMS) were 
generated using a Micromass Quattro Ultima. High resolution mass 
spectrometry was performed at the National Mass Spectrometry 
Centre Swansea using MAT95 or MAT900 in the electrospray 
ionisation (ESI) mode. Analytical thin-layer chromatography (TLC) 
was performed on precoated silica plates 60 F254 (Merck). 
Visualisation of the plates was carried out using UV light (254 nm), 
and/or a solution of permanganate or sulphuric acid followed by 
heating. Flash column chromatography was carried out on Merck 
9385 silica gel 60 (40-63 μm) (Merck). All solvents were of reagent 
grade.  
General method for the synthesis of sialosyl disulfides  
A solution of 3 (0.1 mmol) in ethyl acetate (3 ml) was mixed with 
KSAc (0.3 mmol) followed by the addition of symmetrical disulfide 
(0.3 mmol) and diethylamine (0.2 mmol) at RT. After 30 min, the 
reaction mixture was filtered and the filtrate was concentrated 
under vacuum. Column chromatography on silica gel (ethyl acetate 
100%) afforded desired sialosyl disulfides. 
Methyl 2-(benzylsulfanyl) 5-acetamido-4,7,8,9-tetra-O-acetyl-
2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (6a) –
1
H NMR (CDCl3, 600 MHz) δ 1.88 (s, 3H, 
NAc), 1.94, 2.03, 2.17 (4s, 12H, 4OAc), 2.23 (dd, 2H, H-3ax, J3ax,4 12.5 
Hz, J3ax,3eq 12.6 Hz), 2.69 (dd, 1H, H-3eq, J3eq,4 4.2 Hz, J3ax,3eq 12.6 Hz), 
3.81 (s, 3H, COOMe), 4.00 – 4.14 (m, 5H), 4.36 (d, 1H, H-9, J9,9’ 12.5 
Hz), 4.89 (ddd, 1H, H-4), 5.26 (d, 1H, H-6), 5.34 (d, 1H, H-7), 5.39 (m, 
1H, H-8), 7.24 – 7.33 (m, 5H); 
13
C NMR (CDCl3, 100 MHz) δ 14.30, 
20.79, 20.91, 20.96, 21.25, 23.32, 37.54, 44.71, 49.44, 53.25, 62.23, 
67.47, 69.43, 69.79, 75.01, 89.47, 127.77, 128.66 (2C), 129.69 (2C), 
136.41, 168.00, 170.05, 170.21, 170.32, 170.73, 171.09; MS (ES
+
) 
C27H35NO12S2 (629) m/z (%) 630.3 [M+H]+ (100); HRMS (ES
+
) Found 
630.1668, calcd for C27H36NO12S2 630.1673 [M+H]
+
  
Methyl 2-[(4’-fluorobenzyl)sulfanyl] 5-acetamido-4,7,8,9-tetra-O-
acetyl-2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (6b) - 
1
Η ΝΜR (CDCl3, 600 MHz) δ 1.93 (s, 3H, 
NAc), 1.96, 2.04, 2.13, 2.19 (4s, 12H, 4OAc), 2.22 (dd, 1H, H-3a, 
J3ax,3eq 12.5Hz), 2.71 (dd, 1H, H-3eq, J3eq,4 4.6 Hz, J3ax,3eq 12.5Hz), 3.81 
(s, 3H, COOMe), 3.99 (d, 1H, 
2
J 12.1 Hz), 4.02-4.07 (m, 3H, H-5, NH, -
CH), 4.11 (dd, 1H, H-9a, J8,9a 5.4 Hz, J9a,9b 12.5 Hz), 4.35 (dd, 1H, H-
9b, J8,9b 2.7 Hz, J9a,9b 12.5 Hz), 4.89 (m, 1H, H-4), 5.27 (d, 1H, H-6, J5,6 
9.3 Hz), 5.32 (dd, 1H, H-7, J6,7 1.5 Hz, J7,8 8.2 Hz), 5.39 (m, 1H, H-8), 
7.00 (d, 1H, 
3
J 8.5 Hz), 7.01 (d, 1H, 
3
J 8.5 Hz), 7.32 (d, 1H, 
3
J 8.5 Hz), 
7.33 (d, 1H, 
3
J 8.5 Hz); 
13
C NMR
 
(CDCl3, 100 MHz) δ 20.78, 20.86, 
20.92, 21.24, 23.18, 37.48, 43.82, 49.73, 53.32, 62.08, 67.36, 68.94, 
69.58, 74.75, 89.58, 114.21, 115.48, 115.65, 120.75, 131.36, 131.41, 
167.86, 170.09, 170.20, 170.73, 171.15, 171.29; MS (ES
+
) 
C27H34FNO12S2 (647.69) m/z (%) 648.4 [M+H]+ (20), 665.2 [M+NH4]+ 
(100), 670.1 [M+Na]+ (40); HRMS (ES
+
) Found 648.1567, calcd for 
C27H35FNO12S2 648.1579[M+H]
+
  
Methyl 2-(cynnamylsulfanyl) 5-acetamido-4,7,8,9-tetra-O-acetyl-
2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (6c) - 
1
Η ΝΜR (CDCl3, 600 MHz) δ 1.90 (s, 3H, 
NAc), 1.99, 2.03, 2.13, 2.18 (4s, 12H, 4OAc), 2.24 (dd, 1H, H-3ax, 
J3ax,4 11.8 Hz, J3ax,3eq 12.5 Hz), 2.70 (dd, 1H, H-3eq, J3ax,4 4.6 Hz, 
J3ax,3eq 12.5 Hz), 3.62 (m, 2H), 3.81 (s, 3H, COOMe), 4.00 (d, 1H, NH, 
JNH,5 10.8 Hz), 4.06 (m, 1H, H-5), 4.13 (dd, 1H, H-9a, J8,9a 5.5 Hz, J9a,9b 
12.3 Hz), 4.38 (d, 1H, H-9a, J9a,9b 12.3 Hz), 4.88 (m, 1H, H-4), 5.23 (d, 
1H, H-6, J5,6 9.7 Hz), 5.32 (d, 1H, H-7, J7,8 8.1 Hz), 5.37 (m, 1H, H-8), 
6.20 (m, 1H), 6.56 (d, 1H, 
E
J 15.4 Hz), 7.24 (m, 1H), 7.30 (m, 2H), 
7.39 (m, 2H); 
13
C NMR
 
(CDCl3, 100 MHz) δ 20.85, 20.88, 20.94, 21.24, 
23.25, 37.50, 42.63, 49.50, 53.28, 62.39, 67.46, 69.46, 69.71, 74.71, 
89.15, 123.32, 126.60 (2C), 127.88, 128.68 (2C), 134.99, 136.65, 
162.97, 168.01, 170.09, 170.15, 170.72, 170.74, 171.12; MS (ES
+
) 
C29H37NO12S2 (655.18) m/z (%) 656.33 [M+H]+ (20), 678.24 [M+Na]+ 
(55);  HRMS (ES
+
) Found 673.2086, calcd for C29H37NO12S2 
673.2095[M+NH4]
+
  
Methyl 2-[phenylsulfanyl] 5-acetamido-4,7,8,9-tetra-O-acetyl-
2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (7a) 
1
H NMR (CDCl3, 400 MHz) δ 1.87 (s, 3H, 
NAc), 2.02,  2.03, 2.05, 2.12 (4s, 12H, OAc), 2.19 (dd, 1H, H-3ax, J3ax,4 
12.4 Hz, J3ax,3eq 12.8 Hz), 2.75 (dd, 1H, H-3eq, J3eq,4 4.8 Hz, J3eq,3ax 
12.8Hz), 3.48 (s, 3H, COOMe),  3.91 (m, 3H, H-5, H-6, H-9a), 4.25 
(dd, 1H, H-9b, J8,9 2.8 Hz, J9a,9b 12.4 Hz), 4.85 (m, 1H, H-4), 5.10 (m, 
1H, H-8), 5.24 (m, 2H, H-7, NH), 7.21 (m, 1H), 7.32 (m, 2H), 7.55 (d, 
2H, 
3
J 7.8 Hz);  
13
C NMR (CDCl3, 100 MHz) δ 20.74, 20.87, 21.15, 
23.21, 37.18, 49.25, 52.90, 61.71, 67.11, 69.46, 69.63, 74.66, 76.72, 
77.04, 77.36, 86.49, 127.15, 128.01, 128.75, 136.12, 167.67, 169.89, 
170.08, 170.26, 170.70, 170.94; MS (ES
+
) C26H33NO12S2 (615) m/z 
616.29 [M+H]
+
 (47)
 
 638.28 [M+Na]
+ 
(100);
 
HRMS (ES
+
) Found 
638.1330, calcd for C26H33NO12S2Na 638.1336 [M+Na]
+
  
Methyl 2-[2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)] 5-
acetamido-4,7,8,9-tetra-O-acetyl-2,3,5-trideoxy-2-thio-β-D-
glycero-D-galacto-2-nonulopyranosonate (7b) - 
1
H NMR (CDCl3, 400 
MHz) δ 1.86 (s, 3H, NAc), 1.98, 2.01, 2.03, 2.05, 2.08, 2.09, 2.14, 
2.19 (s, 24 H, 8 OAc), 2.79 (dd, 1H, H-3eqNeu, J3ax,4 4.4 Hz, J3ax,3eq 12.8 
Hz), 3.79 (s, 3H, OMe), 3.88-4.17 (m, 5H, H-5glu, NH, H-5Neu, H-7Neu, 
H-9aNeu), 4.33-4.39 (m, 2H, H-6Neu, H-9bNeu), 4.64 (d, 1H, H-1glu, J1,2 
10.0 Hz), 4.85 (m, 1H, H-4Neu), 4.94 (dd, 1H, H-2glu, J1,2 10.0 Hz, J2,3 
9.2 Hz), 5.12 (m, 2H, H-4glu and H-6aglu), 5.31 (m, 2H, H-6bglu and H-
8Neu), 5.55 (dd, 1H, H-3glu, J2,3 9.2 Hz, J3,4 9.2 Hz); 
13
C NMR
 
(CDCl3, 100 
MHz) δ 14.16, 20.55, 20.57, 20.66, 20.71, 20.79, 20.98, 23.14, 
38.42, 49.16, 52.89, 50.34, 61.71, 62.36, 67.46, 68.08, 68.83, 69.72, 
70.46, 73.51, 75.05, 75.60, 87.08, 90.81, 167.04, 169.40, 169.43, 
169.99, 170.07, 170.13, 170.32, 170.60, 170.71, 170.82, 171.07; MS 
(ES
+
) C34H47NO21S2 (869.2) m/z (%) 870.22 [M+H]+ (36), 892.20 
[M+Na]+ (100); HRMS (ES
+
) Found 887.2414, calcd for 
C34H47NO21S2NH4 887.2420 [M+NH4]
+
  
Methyl 2-[methylsulfanyl] 5-acetamido-4,7,8,9-tetra-O-acetyl-
2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (7c) - 
1
H NMR (CDCl3, 400 MHz) δ 1.88 (s, 3H, 
NAc), 2.03, 2.04, 2.12, 2.15 (s, 12 H, 4 OAc), 2.22 (dd, 1H, H-3ax, 
J3ax,4 12.0 Hz, J3ax,3eq 12.8 Hz), 2.50 (s, 3H, SSMe), 2.70 (dd, 1H, H-
3eq, J3ax,4 4.7 Hz, J3ax,3eq 12.8 Hz), 3.81 (s, 3H, OMe), 4.01 (m, 2H, H-
5, H-6), 4.13 (m, 1H, H-9a), 4.39 (m, 1H, H-9b), 4.89 (m, 1H, H-4), 
5.21 (d, 1H, NH, J5,NH 9.6 Hz), 5.31 (m, 2H, H-6, H-8); 
13
C NMR
 
(CDCl3, 
100 MHz) δ 20.72, 20.79, 20.99, 21.05, 23.15, 24.74, 37.36, 49.41, 
53.03, 62.15, 67.46. 69.52, 69.72, 74.91, 89.12, 168.00, 169.95, 
170.08, 170.15, 170.59, 170.89; MS (ES
+
) C21H31NO12S2 (553.6) m/z 
(%) 554.26 [M+H]+ (18), 576.25 [M+Na]+ (100); HRMS (ES
+
) Found 
554.1348, calcd for C21H32NO12S2 554.1348 [M+H]
+
  
Methyl 2-[(2-hydroxyethyl)methylsulfanyl] 5-acetamido-4,7,8,9-
tetra-O-acetyl-2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (7d) -  
1
H NMR (CDCl3, 400 MHz) δ 1.87 (s, 3H, 
NAc), 2.02, 2.06, 2.13, 2.15 (4s, 12H, 4OAc), 2.24 (dd, 1H, H-3ax, 
J3ax,4 12.0 Hz, J3ax,3eq 12.6 Hz), 2.68 (dd, 1H, H-3eq, J3ax,4 4.8 Hz, 
J3ax,3eq 12.6 Hz), 2.76 (t, 1H, OH, J 6.3 Hz), 2.94 (m, 1H, SCH2CH2OH), 
3.08 (m, 1H, SCH2CH2OH), 3.81 (s, 3H, COOMe), 3.85 (m, 2H, 
CH2CH2OH), 4.01 (m, 3H, H-5, H-6, H-9a), 4.39 (dd, 1H, H-9b, J8,9 2.8 
Hz, J9a,9b 12.4 Hz), 4.88 (m, 1H, H-4), 5.23 (m, 1H, NH, J5,NH 9.6 Hz), 
5.26 (dd, 1H, H-7, J 1.6 Hz, J 8.0 Hz), 5.36 (m, 1H, H-8); 
13
C NMR
 
(CDCl3, 100 MHz) δ 20.75, 20.79, 21.09, 21.38, 23.14, 37.41, 39.98, 
49.34, 53.15, 60.41, 60.50, 62.73, 67.45, 69.00, 74.76, 89.37, 
167.87, 170.11, 170.17, 170.41, 170.91, 171.11;MS (ES
+
) 
C22H33NO13S2 (583.6) m/z (%) 584 [M+H]+ (14), 606.24 [M+Na]+ 
(100); HRMS (ES
+
) Found 601.1722, calcd for C22H33NO13S2NH4 
601.1732 [M+NH4]
+
  
Methyl 2-[(5-chloropyridin-2-yl)sulfanyl]-5-acetamido-4,7,8,9-te                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
tra-O-acetyl-2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (7e) 
1
H NMR (CDCl3, 400 MHz) δ 1.86 (s, 3H, 
NAc), 2.01, 2.03, 2.03, 2.11 (4s, 12H, 4OAc), 2.24 (dd, 1H, H-3ax, 
J3ax,4 12.0 Hz, J3ax,3eq 12.4 Hz), 2.68 (dd, 1H, H-3eq, J3ax,4 4.8 Hz, 
J3ax,3eq 12.8 Hz), 3.73 (s, 3H, COOMe), 4.01 (m, 3H, H-5, H-6, H-9a), 
4.39 (dd, 1H, H-9b, J8,9 2.8 Hz, J9a,9b 12.4 Hz), 4.91 (m, 1H, H-4), 5.01 
(m, 1H, H-8), 5.18 (d, 1H, NH, J5,NH 8.0 Hz), 5.27 (m, 1H, H-7), 7.75 
(dd, 1H, H4`, 
4
J 2.2 Hz 
3
J 8.6 Hz), 7.78 (d, 1H, H3`, 
3
J 8.6 Hz), 8.38 (d, 
1H, H6`, 
4
J 2.2 Hz); 7.68, 7.80, 8.40, (m, 3H, H-2’, H-3’, H-4’) ;  
13
C 
NMR (CDCl3, 100 MHz) δ 14.16, 20.55, 20.70, 20.77, 20.98, 23.11, 
37.41, 49.28, 53.24, 60.35, 62.00, 67.20, 68.86, 69.37, 74.70, 87.57, 
121.58, 136.82, 147.64, 157.35, 167.69, 169.82, 169.85, 170.14, 
170.53, 170.81; MS (ES
+
) C25H31ClN2O12S2 (650.1) m/z (%) 651.27 
[M+H]+ (100), 673.11 [M+Na]+ (22);                                                                                                                                                                                                                                                                                    
HRMS (ES
+
) Found 651.1069, calcd for C25H32ClN2O12S2 651.1080 
[M+H]
+
                                                                                                                                                                                                                                                                                      
Methyl 2-[(cyclohexyl)methylsulfanyl] 5-acetamido-4,7,8,9-tetra-
O-acetyl-2,3,5-trideoxy-2-thio-β-D-glycero-D-galacto-2-
nonulopyranosonate (7f) - 
1
H NMR (CDCl3, 400 MHz) δ 1.31 (m, 7H), 
1.66 (m, 1H), 1.82 (m, 2H), 1.90 (s, 3H, NAc), 2.07, 2.10, 2.14, 2.17 
(4s, 12H, 4OAc), 2.l (dd, 1H, H-3ax, J3ax,4 12.0 Hz, J3ax,3eq 12.8 Hz), 
2.68 (dd, 1H, H-3eq, J3ax,4 4.8 Hz, J3ax,3eq 12.8 Hz), 2.95 (m, 1H), 3.83 
(s, 3H, COOMe), 3.93 (m, 2H, H-5, H-6), 4.07 (dd, 1H, H-9a, J8.9a 5.2 
Hz, J9a,9b 12.6 Hz), 4.41 (dd, 1H, H-9b, J8,9 2.4 Hz, J9a,9b 12.6 Hz), 4.92 
(m, 1H, H-4), 5.34 (m, 3H, NH, H-7, H-8); 
13
C NMR (CDCl3, 100 MHz) δ 
13.55, 14.63, 21,27, 21.29, 21.51, 21.86, 23.64, 26.16, 37.73, 40.45, 
43.32, 49.84, 50.15, 53.49, 62.47, 67.92, 69.93, 70.36, 75.24, 88.96, 
168.81, 170.32, 170.38, 170.64, 171.01, 171.38; MS (ES
+
) 
C26H39NO12S2 (621.7) m/z (%) 622.26 [M+H]+ (8), 644.32 [M+Na]+ 
(100); HRMS (ES
+
) Found 622.1974, calcd for C26H33NO12S2 622.1986 
[M+H]
+
. 
General method for the synthesis of glycosyl disulfides – To a 
solution of 8 (0.1 mmol) in ethyl acetate (2 ml) was added hydrazine 
hydrate (0.3 mmol) followed by symmetrical disulfide (0.5 mmol) at 
RT. After 4-5, the reaction mixture was quenched with sat sol 
NaHCO3 (20 ml) and extracted ethyl acetate (3 x 20 ml). The organic 
phase was dried over MgSO4, filtered and the filtrate concentrated 
under vacuum. Column chromatography on silica gel (petroleum 
ether/ethyl acetate 2:1) afforded desired glycosyl disulfides. 
2-Hydroxyethyl-(2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl)disulfide (9a) 
1
H NMR (CDCl3, 400 MHz,) δ 1.97, 
1.99, 1.99, 2.05 (s, 12H, OAc), 2.38 (bs, 1H,OH), 2.88 (m, 2H, 
CH2CH2OH), 3.73 (ddd, 1H, H-5, J5,6a 2.0 Hz, J5,6b 4.7 Hz, J4,5 = 9.6 
Hz,), 3.83 (t, J = 5.9 Hz, 2H, CH2CH2OH), 4.14 (dd, 1H, H-6a. J5,6a 2.0 
Hz, J6a,6b 12.4 Hz), 4.21 (dd, 1H, H-6b, J5,6b 4.7 Hz, J6a,6b12.5 Hz),  4.52 
(d, 1H, H-1, J1,2 9.6 Hz), ), 5.06 (dd, 1H, H-4, J3,4 9.6 Hz, J4,5 9.6 Hz), 
5.24 (m, 2H, H-2, H-3); 
13
C NMR (CDCl3, 100 MHz) δ 20.48, 20.51, 
20.57, 20.63, 41.91, 60.02, 61.78, 67.97, 69.09, 73.75, 76.24, 87.14, 
169.10, 169.30, 170.11, 170.61; MS (ES
+
) C15H22O10S2 (426) m/z (%) 
463.21 [M+Na]+ (100);  
4-Flurorobenzyl-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-
disulfide (9e) - 
1
H NMR (CDCl3, 400 MHz) δ 2.01, 2.02, 2.04, 2.07 
(4s, 12H, OAc), 3.75 (m, 1H, H-5) 3.99 (s, 2H, SSCH2PhF), 4.19 (dd, 
1H, H-6a, J5,6a 2.4 Hz, J6a,6b 12.4 Hz), 4.27 (dd, 1H, H-6b, J5,6b 4.8 Hz, 
J6a,6b 12.4 Hz), 4.53 (d, 1H, H-1, J1,2 9.6 Hz), 5.13 (dd, 1H, H-4, J3,4 9.6 
Hz, J4,5 9.6 Hz), 5.25 (dd, 1H, H-3, J2,3 9.6 Hz, J3,4 9.6 Hz), 5.32 (dd, 
1H, H-2, J1,2 9.6 Hz, J2,3 9.6 Hz), 7.00 (dd, 2H, H3`, 
3
J 8.4 Hz, JH,F 8.8 
Hz). 7.27 (m, 2H); 
13
C NMR (CDCl3, 100 MHz) δ 20.53, 20.55, 20.60, 
20.67, 43.53, 62.09, 68.11, 69.16, 73.83, 87.79, 115.28 (2C), 131.10 
(2C), 169.07, 169.36, 170.13, 170.41; MS (ES
+
) C21H25FO9S2 (504) 
m/z (%) 527.14 [M+Na]+ (100); HRMS (ES
+
) Found 522.1249, calcd 
for C21H29FO9S2N 522.1262 [M+NH4]
+
. 
Methyl-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-disulfide (9f) – 
1
H NMR (CDCl3, 400 MHz) δ 2.01, 2.03, 2.08 (3s, 12H, 4OAc), 2.48 (s, 
3H, SSCH3), 3.74 (m, 1H, H-5), 4.17 (dd, 1H, H-6a, J5,6a 2.4 Hz, J6a,6b 
12.4 Hz), 4.23 (dd, 1H, H-6b, J5,6b 4.8 Hz, J6a,6b 12.4 Hz), 4.57 (d, 1H, 
H-1, J1,2 9.6 Hz), 5.11 (dd, 1H, H-4, J3,4 9.6 Hz, J4,5 9.6 Hz), 5.25 (dd, 
1H, H-3, J2,3 9.6 Hz, J3,4 9.6 Hz), 5.30 (dd, 1H, H-2, J1,2 9.6 Hz, J2.3 9.6 
Hz);
 13
C NMR (CDCl3, 100 MHz) δ 20.54, 20.57, 20.63, 20.66, 24.62, 
60.35, 62.09, 68.15, 69.11, 73.89, 88.03, 169.11, 169.35, 170.18, 
170.49; MS (ES
+
) C15H22O9S2 (410.07) m/z (%) 433.20 [M+Na] + 
(100); HRMS (ES
+
) Found 428.1036, calcd for C15H22O9S2 HRMS (ES
+
) 
Found 418.1036, calcd for C15H26O9S2N 428.1043 [M+NH4]
+
. 
5-chloropyridin-1-sulfanyl -(2,3,4,6-tetra-O-acetyl-β-d-
glucopyranosyl)disulphide (9g) -
1
H NMR (CDCl3, 400 MHz) δ 2.00, 
2.02, 2.10, 2.13 (4s, 12H, OAc), 3.79 (m, 1H, H-5), 4.22 (dd, 1H, H6a, 
J5,6a 2.0 Hz J6a,6b  12.4 Hz), 4.25 (dd, 1H. H6b, J5,6b 4.4 Hz, J6a,6b 12.4 
Hz), 4.66 (d, 1H, H-1, J1,2 10.0 Hz)), 5.06 (dd, 1H, H-4, J4,5 9.6 Hz, J3,4 
10.0 Hz, 5.17 (d, 1H, H-2, J2,3 9.6 Hz, J1,2 10.0 Hz), 5.25 (dd, 1H, H-3, 
J2,3 9.6 Hz, J3,4 10.0 Hz), 7.34 (d, 1H, 
3
J 8.0 Hz), 7.42 (d, 1H, 
3
J 8.0 Hz), 
(7.66 (s, 1H);
 13
C NMR (CDCl3, 100 MHz) δ 14.17, 20.53, 20.62, 20.75, 
21.00, 60.37, 61.60, 67.94, 69.78, 73.89, 76.19, 87.28, 138.14, 
169.16, 169.28, 170.09, 170.68, 210.01; MS (ES
+
) C19H22ClNO9S2 
(507) m/z (%) 508.17 [M+H]
+
(100), 503.16 [M+Na]+ (24); HRMS 
(ES
+
) Found 508.0489, calcd for C19H22ClNO9S2 508.0497 [M+H]
+ 
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